Meanwhile chronic hyperglycaemia, insulin resistance and low grade inflammation damage the cerebral microvasculature, reduce BDNF levels, and through oxidative stress and advanced glycation end products promote Aβ accumulation and tau hyper phosphorylation, thereby accelerating cognitive decline [66–68]. This evidence concerns the gene MAPT and Hyperglycemia.